BeOne Medicines Ltd. (ONC)
318.66
-0.03
(-0.01%)
USD |
NASDAQ |
Dec 10, 11:03
BeOne Medicines EPS Diluted (Quarterly): 1.092 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Jazz Pharmaceuticals Plc | 4.081 |
| AC Immune SA | -0.1964 |
| CRISPR Therapeutics AG | -1.166 |
| Addex Therapeutics Ltd. | -2.099 |
| NewCelX Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 125.01M |
| Revenue (Quarterly) | 1.414B |
| Total Expenses (Quarterly) | 1.289B |
| Enterprise Value | 33.08B |
| Gross Profit Margin (Quarterly) | 83.86% |
| Profit Margin (Quarterly) | 8.84% |
| Earnings Yield | 0.16% |
| Operating Earnings Yield | 0.52% |
| Normalized Earnings Yield | 0.2188 |